Have $2,000? 2 Magnificent Stocks Ready for a Bull Run
Stocks across a range of industries and sectors have dealt with unique challenges over the last few years. While some companies are still dealing with the effects of a slowdown in growth following pandemic highs, it's important to look at the underlying businesses and not just stock prices to see if a long-term buying proposition remains intact.
If you have $2,000 to invest in stocks right now, there are plenty of wonderful businesses begging to be bought. Here are two such names to consider for your buy basket right now, both of which the market has heavily discounted over the trailing 12 months.
Pfizer (NYSE: PFE) has had a significant adjustment as a business after the height of its successes during the pandemic from the COVID-19 vaccine, Comirnaty, and oral antiviral medication, Paxlovid. While it was inevitable that there would be a steep sales cliff after the pandemic-era demand for these products waned, investor sentiment has not been kind to the stock in recent months.
Source Fool.com
Pfizer Inc. Aktie
Die Community bevorzugt Pfizer Inc., mit deutlich mehr Buy- (29) als Sell-Einschätzungen (4).
Ein Kursziel von 41 € für Pfizer Inc. würde eine Steigerung von mehr als 20% gegenüber dem aktuellen Kurs von 27.73 € bedeuten.
